MX2018010856A - Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. - Google Patents

Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.

Info

Publication number
MX2018010856A
MX2018010856A MX2018010856A MX2018010856A MX2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A MX 2018010856 A MX2018010856 A MX 2018010856A
Authority
MX
Mexico
Prior art keywords
value
methods
compositions
devices
functional dyspepsia
Prior art date
Application number
MX2018010856A
Other languages
English (en)
Spanish (es)
Inventor
IRANI-COHEN Zackary
LADERMAN Elisabeth
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of MX2018010856A publication Critical patent/MX2018010856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Glass Compositions (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2018010856A 2016-03-09 2017-03-09 Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. MX2018010856A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662305680P 2016-03-09 2016-03-09
PCT/US2017/021643 WO2017156313A1 (en) 2016-03-09 2017-03-09 Compositions, devices, and methods of functional dyspepsia sensitivity testing

Publications (1)

Publication Number Publication Date
MX2018010856A true MX2018010856A (es) 2019-07-10

Family

ID=59789894

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018010856A MX2018010856A (es) 2016-03-09 2017-03-09 Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.

Country Status (8)

Country Link
US (1) US20190120835A1 (cg-RX-API-DMAC7.html)
EP (1) EP3427056A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019509485A (cg-RX-API-DMAC7.html)
CN (1) CN109154607A (cg-RX-API-DMAC7.html)
AU (1) AU2017230706A1 (cg-RX-API-DMAC7.html)
CA (1) CA3016735A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018010856A (cg-RX-API-DMAC7.html)
WO (1) WO2017156313A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3940380A1 (en) 2014-11-14 2022-01-19 Biomerica Inc. Compositions, devices, and methods of ibs sensitivity testing
AU2017230706A1 (en) * 2016-03-09 2018-09-27 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing
JP6943479B2 (ja) 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． うつ病感受性試験の組成物、デバイスおよび方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
WO2005078442A1 (en) * 2004-02-10 2005-08-25 Dantini Daniel C Comprehensive food allergy test
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
WO2007099346A1 (en) * 2006-03-03 2007-09-07 Cambridge Antibody Technology Limited Binding members for ghrelin
US20100227340A1 (en) * 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
CN102341705B (zh) * 2009-03-05 2015-08-19 味之素株式会社 克罗恩氏病诊断试剂
EP2533052A1 (en) * 2011-06-07 2012-12-12 B.R.A.H.M.S GmbH Diagnostic use of proSomatostatin
WO2013106886A1 (en) * 2012-01-20 2013-07-25 Adelaide Research & Innovation Pty Ltd Biomarkers for gastric cancer and uses thereof
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
WO2016122597A1 (en) * 2015-01-30 2016-08-04 Cyrex Laboratories, Llc Simultaneous characterization of igg and iga antibodies to multiple food antigens and c1q-food protein immune complexes
AU2017230706A1 (en) * 2016-03-09 2018-09-27 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing

Also Published As

Publication number Publication date
JP2019509485A (ja) 2019-04-04
EP3427056A4 (en) 2019-11-06
CN109154607A (zh) 2019-01-04
US20190120835A1 (en) 2019-04-25
JP2022031342A (ja) 2022-02-18
EP3427056A1 (en) 2019-01-16
CA3016735A1 (en) 2017-09-14
AU2017230706A1 (en) 2018-09-27
WO2017156313A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
MX2021009297A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs.
Srivastava Why have measures of earnings quality changed over time?
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
MX2023005293A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.
CA2961701C (en) Method and system for determining the local quality of surface data extracted from volume data
MX2018004400A (es) Metodos y sistemas para mejorar la condicion dermica.
BR112018002848A2 (pt) método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular
SG11201900126YA (en) Object selection method and apparatus
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
MX2023006660A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis.
MX2018011166A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia.
MX2018007567A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis.
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
MX2024000466A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad a la enfermedad de crohn.
MX2018010856A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.
MY187907A (en) Methods and snp detection kits for predicting palm oil yield of a test oil palm plant
MX2021000899A (es) Composiciones y metodos para determinar el pronostico de cancer de endometrio.
MX2018013120A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
MX2018015334A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos a la enfermedad de reflujo gastroesofageal.
MX391844B (es) Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra.
GB2552271A (en) A method for diagnosing lung cancer
MX2018007566A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña.
MX2023005604A (es) Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd).
WO2015166353A3 (en) Early detection of preeclampsia
MX2019000143A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión.